Compare Exelixis Inc. Common Stock (EXEL) vs Lumentum (LITE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Lumentum — how do they compare? Exelixis Inc. Common Stock trades at $60.27 (market cap $14.62B), while Lumentum trades at $1,115.92 (market cap $94.99B). The key difference: Lumentum is far larger — about 6.5× Exelixis Inc. Common Stock's market cap, and Lumentum is more actively traded (4,855,776 versus 2,684,957). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Lumentum for 4 Days on average.
| EXEL | LITE | |
|---|---|---|
Market Cap | $14.62B | $94.99B |
Volume | 2,684,957 | 4,855,776 |
Sector | Health | Technology |
52-Week High | $59.13 | $1.13K |
52-Week Low | $34.54 | $149.61 |
Typical Hold Time | 1 Days | 4 Days |
Enterprise Value | $13.95B | $93.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →
